Subscribe to RSS
DOI: 10.1055/a-1680-1572
Surgical Outcomes of Endoscopic Transsphenoidal Pituitary Adenoma Resection in Elderly Versus Younger Patients
Abstract
Introduction Pituitary adenomas (PAs) are one of the most common types of intracranial neoplasm with increased incidence in elderly patients. The outcomes of endoscopic transsphenoidal surgery (ETS) specifically on elderly patients remain unclear.
Methods We performed a retrospective cohort study to compare elderly patients (age ≥65 years) with nonelderly patients (age <65 years) who underwent ETS for PA from January 2005 to December 2020. Surgical outcomes, including extent of resection, complication profile, length of stay, and endocrinopathy rates, were compared between elderly and nonelderly patients.
Results A total of 690 patients were included, with 197 (29%) being elderly patients. Elderly patients showed higher rates of hypertension (p < 0.05), myocardial infarction (p < 0.01), and atrial fibrillation (p = 0.01) but not other comorbidities. Elderly patients also had more frequent optic nerve involvement (72 vs. 61% of cases, p = 0.01). Tumor characteristics and other patient variables were otherwise similar between younger and elderly patients. Postoperative cerebrospinal fluid (CSF) leaks (2 vs. 2%, p = 0.8), 30-day readmission, reoperation, postoperative complications, and postoperative endocrinopathies were similar between younger and older patients. Subdividing patients into age <65, 65 to 79, and >80 years also did not demonstrate a worsening of surgical outcomes with age.
Conclusion For well-selected elderly patients in experienced endoscopic skull base centers, good surgical outcomes similarly to younger patients may be achieved.
Publication History
Received: 27 May 2021
Accepted: 24 October 2021
Accepted Manuscript online:
27 October 2021
Article published online:
31 January 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med 2020; 382 (10) 937-950
- 2 Ntali G, Wass JA. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 2018; 21 (02) 111-118
- 3 Gittleman H, Ostrom QT, Farah PD. et al. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009. J Neurosurg 2014; 121 (03) 527-535
- 4 Kowal P, Goodkind D, He W. An Aging World: 2015. International Population Reports. U.S. Government Printing Office; Washington DC: 2016
- 5 McDowell BD, Wallace RB, Carnahan RM, Chrischilles EA, Lynch CF, Schlechte JA. Demographic differences in incidence for pituitary adenoma. Pituitary 2011; 14 (01) 23-30
- 6 Chen S.H.. et al. Transsphenoidal Approach for Pituitary Adenomas in Elderly Patients. World Neurosurg 2019; 121: e670-e674
- 7 Chinezu R, Fomekong F, Lasolle H. et al. Risks and benefits of endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas in patients of the ninth decade. World Neurosurg 2017; 106: 315-321
- 8 Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Mota JI. Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas. J Neurosurg 2015; 123 (01) 31-38
- 9 Marenco HA, Zymberg ST, Santos RdeP, Ramalho CO. Surgical treatment of non-functioning pituitary macroadenomas by the endoscopic endonasal approach in the elderly. Arq Neuropsiquiatr 2015; 73 (09) 764-769
- 10 Tardivo V, Penner F, Garbossa D. et al. Surgical management of pituitary adenomas: does age matter?. Pituitary 2020; 23 (02) 92-102
- 11 Thakur JD, Corlin A, Mallari RJ. et al. Pituitary adenomas in older adults (≥ 65 years): 90-day outcomes and readmissions: a 10-year endoscopic endonasal surgical experience. Pituitary 2021; 24 (01) 14-26
- 12 Wilson PJ, Omay SB, Kacker A, Anand VK, Schwartz TH. Endonasal endoscopic pituitary surgery in the elderly. J Neurosurg 2018; 128 (02) 429-436
- 13 Yunoue S, Tokimura H, Tominaga A. et al. Transsphenoidal surgical treatment of pituitary adenomas in patients aged 80 years or older. Neurosurg Rev 2014; 37 (02) 269-276 , discussion 276–277
- 14 Pereira EA, Plaha P, Chari A. et al. Transsphenoidal pituitary surgery in the elderly is safe and effective. Br J Neurosurg 2014; 28 (05) 616-621
- 15 Hasegawa Y, Yano S, Sakurama T. et al. Endoscopic surgical treatment for pituitary apoplexy in three elderly patients over the age of 80. Acta Neurochir Suppl (Wien) 2011; 111: 429-433
- 16 Farrell CJ, Nyquist GG, Farag AA, Rosen MR, Evans JJ. Principles of pituitary surgery. Otolaryngol Clin North Am 2016; 49 (01) 95-106
- 17 Little AS, Kelly DF, White WL. et al; TRANSSPHER Study Group. Results of a prospective multicenter controlled study comparing surgical outcomes of microscopic versus fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas: the Transsphenoidal Extent of Resection (TRANSSPHER) Study. J Neurosurg 2019; 132 (04) 1043-1053
- 18 Wang EW, Zanation AM, Gardner PA. et al. ICAR: endoscopic skull-base surgery. Int Forum Allergy Rhinol 2019; 9 (S3): S145-S365
- 19 Azab MA, O'Hagan M, Abou-Al-Shaar H, Karsy M, Guan J, Couldwell WT. Safety and outcome of transsphenoidal pituitary adenoma resection in elderly patients. World Neurosurg 2019; 122: e1252-e1258
- 20 Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta 2003; 337 (1–2): 169-172
- 21 Schlanger LE, Bailey JL, Sands JM. Electrolytes in the aging. Adv Chronic Kidney Dis 2010; 17 (04) 308-319
- 22 Zhan R, Ma Z, Wang D, Li X. (2015) Pure Endoscopic Endonasal Transsphenoidal Approach for Nonfunctioning Pituitary Adenomas in the Elderly: Surgical Outcomes and Complications in 158 Patients. World Neurosurgery 6: 1572-1578